Albemarle Corp (NYSE:ALB) recently reported second quarter earnings of 89 cents, beating the Zacks Consensus Estimate by 17%. Management is upbeat about the remainder of the year, and analysts have been pushing the 2010 estimate higher. Albemarle manufactures specialty chemicals in three segments: Polymer Solutions (41.5% of sales) Catalysts (35.4%) Fine Chemistry (23.1%) The company [...]